TGFB1 and neoplasm: Activation of the AhR/COX2/PGE2 pathway in tumours leads to PGE2 release and EP2 and EP4 activation in different cells, in turn increasing TGF-β release, and TGF-β-induced adenosine, from these cells and thereby contributing to cytolytic cell ‘exhaustion’ [32].